Li et al reported a nomogram for predicting recurrence-free survival (RFS) for a patient with a primary gastrointestinal stromal tumor (GIST). The authors re from Tianjin Medical University, the Second People's Hospital of Liaocheng, Shandong First Medical University, Baodi People's Hospital of Tianjin Boaodi Clinical College and Tianjin General Surgery Institute in China.